Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VitaCBD was a U.S.-based cannabidiol wellness brand focused on hemp-derived consumer health products rather than a traditional drug-development biotech company. Its product lineup included CBD tinctures, juices, edibles, isolates, salves, waxes, oils, and capsules marketed for health and therapeutic-style benefits. The brand originated with mCig and, in February 2017, 80% of the VitaCBD business was sold to Stony Hill Corp., which later became Applied BioSciences. Available secondary sources indicate VitaCBD was subsequently treated as an acquired brand/business and later discontinued or closed as an operating entity. While healthcare-adjacent, the company appears to have operated primarily in cannabinoid wellness and personal products, not in regulated clinical-stage pharmaceutical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VitaCBD.